Posters
« Back
MODEL-AD: Characterization of Familial AD Models (5xFAD, APP/PS1, hTau, 3xTg-AD)
EP28947
Poster Title: MODEL-AD: Characterization of Familial AD Models (5xFAD, APP/PS1, hTau, 3xTg-AD)
Submitted on 14 Aug 2018
Author(s): Adrian Oblak on behalf of the MODEL-AD Consortium
Affiliations: The Jackson Laboratory, Indiana University Stark Neuroscience Institute, Sage Bionetworks, University of California Irvine
This poster was presented at AAIC 2018
Poster Views: 495
View poster »


Poster Information
Abstract: Alzheimer’s disease (AD) is the most common form of dementia, without an
effective treatment. Animal models of AD have been valuable tools to
understand familial or early onset AD, but to date have not been predictive for
translational research. The objective of the Model Organism Development
and Evaluation for Late-onset AD (MODEL-AD) Center is to develop, validate,
and distribute novel mouse models of late-onset AD (LOAD) that can be used
to develop novel therapeutics. We have established pipelines to test current
fAD models across three sites and characterize mice using biochemistry,
histology, functional assays and in vivo MRI and PET imaging, to determine a
standard testing paradigm across all sites. MODEL-AD is a consortium
involving Indiana University, The Jackson Laboratory, University of California-
Irvine and Sage Bionetworks.
Summary: Overview of the MODEL-AD characterization of well established Alzheimer's mouse modelsReport abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Functional Assay of Neural Activity with Cell-Based Neural Culture Models and Microelectrode Array Technology for Proconvulsant Risk Assessment in the Neutox Pilot Study
Millard, D.C.; Hayes, H.B.; Nicolini, A.M.; Arrowood, C.A.; Clements, M;

Multiplex miRNA Profiling for Biomarker Discovery and Verification Studies Using the FirePlex® Platform
M. Tackett, B. Heinrich, I. Diwan, G. Tejada, C. Rafferty, E. Atabakhsh, and D. Pregibon

Accelerating high-throughput screening with FirePlex®-HT:An automatable, multiplex immunoassay using FirePlex® Particle Technology
A. Perea, B. Heinrich, W. Austin, C. Rafferty, M. Camilleri, L. To, E. Atabakhsh, and D. Pregibon

PEAKS™ Software for the processing of timsTOF Pro PASEF data: identification and label-free quantitation
Markus Lubeck(1), Heiner Koch(1), Scarlet Beck(1), Paul Savage(2), Oliver Raether(1), Pierre-Olivier Schmit(2) Paul Shan (3) and Gary Kruppa (4)

Platinum™ SuperFi™ DNA Polymerase for the highest success in PCR
Rasa Sukackaitė, Martyna Simutytė, Skaistė Valinskytė, Laurynas Vanagas, Karolis Matjošaitis, Renata Rimšelienė, Remigijus Skirgaila.